Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VALEANT PHARMACEUTICALS INTL INC T.VRX

"Valeant Pharmaceuticals is a global specialty pharmaceutical firm with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The firm also has a branded generics business that operates primarily in Latin America, Eastern Europe, and Asia."


TSX:VRX - Post by User

Comment by Spear2000on May 03, 2016 5:11pm
222 Views
Post# 24838376

RE:RE:Warm welcome to Papa

RE:RE:Warm welcome to PapaIt was definitely up from that, but also:

- People had time to digest what Ackman said on CNBC. (they will pay debt from free cash flow and other methods without selling key businesses which keeps growth in the picture).  Along with a lot of other well presented points.

- Papa took the office

- The morning showed support against a broader down market which proved a bottom and gave confidence to buyers.

- Munger said Ackman was a very smart guy who has made good calls in the past and said he is right about Herbalife.

Basically everything is turning in Valeants favor with limited downside.  They can absolutely pay their debt with selling a few non-core assets as a last resort to bolster their already substantial and growing free cash flow of $2 billion per year.
<< Previous
Bullboard Posts
Next >>